Price $37.62 |
Market Cap
2.02B
|
Sector Health Care |
Div. Growth
6.10%
|
|
P/E
28.1
|
P/B
3.76
|
P/S
1.04
|
Dividend %
0.50%
|
|
P/CF
-
|
P/FCF
78.5
|
Op. Cash Flow
149.3K
|
FCF
0.5
|
|
Op. Margin
6.00%
|
Net Margin
3.60%
|
ROE
13.90%
|
ROI
7.00%
|
|
ROA
6.40%
|
EPS Growth
55.90%
|
Current Ratio
1.6
|
Debt/Equity
61.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.24 | - | - | 28.5M | Strong Buy |
| Tenet Healthcare Corp (THC) | $28.07 | - | - | 3.36B | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.90 | - | - | 72.7M | Strong Buy |
| Champions Oncology Inc (CSBR) | $14.22 | - | - | 95.9M | Strong Buy |
| Endo International PLC (ENDP) | $16.25 | - | - | 3.74B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
